Transparency
Market Research’s new report within the medical devices industry sheds light on
the growth pattern of the anti-adhesion products market. The report, titled
“Anti-Adhesion Products Market – Global Industry Analysis, Size, Share, Growth,
Trends and Forecast, 2013 – 2019,” discusses how the growing number of
surgeries performed is creating new economic opportunities in the market.
About 50%
to 90% of patients that undergo surgery are victims to post-surgical adhesion.
This is a serious problem where the wrong tissues connect with each other after
a surgery. Some of the more common problems caused by post-surgical adhesion
include intestinal blockage, pelvic pain, numbness, and infertility. These
complications will vary according to the location of the surgery, the type of
adhesion, and the magnitude of the adhesion.
Brochure
Download for Detailed Analysis: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1506
Anti-adhesion
products can be envisioned as barriers between the healing tissues and the
surrounding healthy tissues. Most anti-adhesion films, fabrics, or gels, are
designed to dissolve after a certain period of time, removing the necessity of
further medical intervention. These products are usually dissolved into bodily
fluids and are excreted naturally.
The
global anti-adhesion products market identifies these adhesions based on their
location, into pelvic, intraperitoneal, and abdominal adhesions. The market
size is therefore directly proportional to the surgical procedures that are
most likely to cause adhesion. These include most types of plastic surgeries,
gynecological surgeries, thoracic surgeries, and abdominal surgeries.
Therefore, the global anti-adhesion products market is currently driven by the
increasing number of the above surgical procedures.
Of the
major geographical regions of the global anti-adhesion products market, North
America, has visibly dominated it for quite a few years. One of the primary
reasons for this region’s dominance is the high rate of approval of
anti-adhesive products by the U.S. FDA. At the same time, this region is
showing a high demand for gynecological and gastrointestinal surgeries. Similar
cases can be made regarding the rapid growth of the anti-adhesion products
market in the Asia Pacific region. This is especially true in the case of the
burgeoning medical tourism market in the Asia Pacific, which is another driver
for the global anti-adhesion products market.
The
future of the global anti-adhesion products market is expected to hold the
release of products that are increasingly efficient and cost-effective. This
will further ramp up the growth rate of the global anti-adhesion products
market.
Key
players in the global anti-adhesion products market include MAST Biosurgery
AG., LifeCell Corporation, Genzyme Corporation, Angiotech Pharmaceuticals,
Inc., Anika Therapeutics, Inc., WL Gore, Baxter International, and Johnson
& Johnson.
Some of
the more commonly used anti-adhesion products around the world include
Seprafilm, Interseed, and Surgiwrap.
No comments:
Post a Comment